Remove 2024 Remove Access Remove Clinical Trials Remove Safety
article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

article thumbnail

Green Light Law Group: Oregon Psilocybin Advisory Board Approves Training and Products Recommendations

Cannabis Law Report

Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours). Psilocybin Pharmacology, Neuroscience, and Clinical Research (12 Hours). Programs shall train students on how to proactively make psilocybin services accessible to people with disabilities. Core Psilocybin Facilitation Skills (16 Hours). info@gl-lg.com

Law 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Guest Post: Denmark’s pilot pharma trial attracts first-movers

Cannabis Law Report

Europe, forecasted to be the world’s biggest legal cannabis market by 2024 will exceed North America, the dominant market today, according to Prohibition Partners. Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. Generation1.ca.

article thumbnail

Dentons: Cannabis Group Weekly Alert – August 2019 #3

Cannabis Law Report

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements. billion by 2024.

Banking 45